|
1）循環器病の診断と治療に関するガイドライン（2011年度合同研究班報告）．肺高血圧症治療ガイドライン 2012年改訂版
|
|
|
|
|
2）Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009; 360: 1989-2003
|
|
|
|
|
3）Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum. 2006; 54: 3043-50
|
|
|
|
|
|
4）Overbeek MJ, Vonk MC, Boonstra A, et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J. 2009; 34: 371-9
|
|
|
|
|
|
5）Günther S, Jaïs X, Maitre S, et al. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum. 2012; 64: 2995-3005
|
|
|
|
|
|
6）Mathai SC, Hummers LK, Champion HC, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum. 2009; 60: 569-77
|
|
|
|
|
|
7）Hinchcliff M, Fischer A, Schiopu E. et al. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS）: baseline characteristics and description of study population. J Rheumatol. 2011; 38: 2172-9
|
|
|
|
|
|
8）Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC） and the European Respiratory Society (ERS）, endorsed by the International Society of Heart and Lung Transplantation (ISHLT）. Eur Heart J. 2009; 30: 2493-537
|
|
|
|
|
|
9）Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology. 2004; 43: 461-6
|
|
|
|
|
|
10）Coghlan JG, Denton CP, Grünig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014; 73: 1340-9
|
|
|
|
|
|
11）Becker MO, Kill A, Kutsche M, et al. Vascular Receptor Autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med. 2014; 190: 808-17
|
|
|
|
|
|
12）Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013; 144: 1346-56
|
|
|
|
|
|
13）Walker KM, Pope J. Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts. Semin Arthritis Rheum. 2012; 42: 42-55
|
|
|
|
|
|
14）Sitbon O, Jaïs X, Savale L, et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J. 2014; 43: 1691-7
|
|
|
|
|
|
15）Hoeper MM, Barst RJ, Bourge RC, et al. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation. 2013; 127: 1128-38
|
|
|
|
|
|
16）Overbeek MJ, Boonstra A, Voskuyl AE，et al. Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Res Ther. 2011; 13: R61
|
|
|
|
|
|
17）Jordan S, Distler JH, Maurer B, et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR） group. Ann Rheum Dis. 2014 Jan 17. doi: 10. 1136/annrheumdis-2013-204522. [Epub ahead of print]
|
|
|
|
|
|
18）National Institutes of Health Clinical Center. A randomized, double-blind, placebo-controlled, phase II multicenter trial of a monoclonal antibody to CD20 (rituximab） for the treatment of systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH）. NCT01086540. Bethesda, MD: National Institutes of Health; 2012. http://clinicaltrials.gov/ct2/show/record/NCT01086540 . Accessed December 12, 2012
|
|
|
|
|
|
19）Khan IY, Singer LG, de Perrot M, et al. Survival after lung transplantation in systemic sclerosis. A systematic review. Respir Med. 2013; 107: 2081-7
|
|
|
|
|